Author: Piers Townley

Earlier this month, NHS England released their ‘Interim NHS People’s Plan’ detailing what measures will be implemented in and ahead of their full workforce proposal

Thanks to the support of our community, we’re pledging more than £3.7m to UK and international teams working towards our twin goals: doubling brain tumour survival and halving the harm caused by the disease

After undergoing an interim analysis, a phase 3 clinical trial called Toca 5 that tests a gene therapy in patients with recurrent brain cancer, will continue

Side by side, stride by stride, let’s pick up the pace of progress

Deputax-M failed to meet its target overall survival during an interim analysis of a phase 3 clinical trial in glioblastoma

Nivolumab, an immunotherapy drug, has been unsuccessful in improving overall survival in a phase 3 clinical trial when tested in newly diagnosed glioblastoma with unmethylated MGMT

New research from one of our funded grants gives much needed insight into group 3 and 4 medulloblastoma

There have been a number of headlines over the last two days about a ‘new treatment’ that may save thousands of lives for brain tumour patients

A new type of drug that targets a particular protein could become the first ever treatment designed for children with diffuse midline gliomas (formerly known as DIPG)

This weekend marks a year since Tessa Jowell died from a brain tumour

Research presented recently at a conference in Milan showed that a particular type of radiation therapy could help spare children’s memory and thinking when they undergo treatment for brain tumours

A research team from Germany has used artificial intelligence to improve the assessment of treatment response in brain tumours

NHS England are currently running a questionnaire to find out more about people’s experiences of Personal Health Budgets, which could feed into and shape the future of personalised healthcare

The Charity’s corporate partnerships officer Steve Salazar, has been pounding the training miles

A recent study highlights gaps in neuro-onoclogy services provided nationally

Recent research has shown that sex differences impact outcomes for people diagnosed with a glioblastoma. These differences go beyond hormone influences and were found to be intrinsic to tumour cells

We explore some of the barriers that will need to be overcome in order to implement the NHS Long Term Plan.

In this second part of our coverage we look at what’s missing form the NHS Long Term Plan

Today, the NHS Long Term Plan has been published setting out the future of NHS services. The plan has been eagerly awaited by healthcare professionals, charities and patients alike

Research, funded by us as part of the INSTINCT programme, has found differences between aggressive atypical teratoid rhabdoid tumours (ATRTs) and other brain

Our successful Ask the Researcher event will give you the chance to hear more about how we’re moving closer to a cure

The All Party Parliamentary Group on Children, Teenagers and Young Adults with Cancer (APPG CTYAC) is a cross-party group which is raising awareness and representing young people who have been personally affected by cancer

Our scientists in Heidelberg and London have discovered what drives the unpredictable growth of low grade brain tumours

On Wednesday we hosted a Parliamentary reception to celebrate the accomplishments and progress that has been made in this disease area since the launch of our strategy in 2015